← Leaderboards
Everett E Vokes
University Of Chicago
$4,130,384
Attributed
$4,130,384
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2006–12$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$5,391,460 · 7
By mechanism
N01$3,041,406 · 2
P50$1,261,076 · 1
P30$768,445 · 3
U01$320,533 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Elaine Fuchs$46,673,928
- Anthony G Montag$572,519
- Julie Karen Johnson$547,340
- Chad Roland Haney$152,974
- Sara Branco$17,638
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsFacultyFundingCytotoxic AgentEnrollmentAntineoplastic AgentsCancer PatientDrug KineticsFosteringCancer And Leukemia Group BChicagoClinical InvestigatorCytostaticsDirect CostsGenotypeClinical Trials Cooperative GroupClinical Trials DesignConduct Clinical TrialsCombined Modality TherapyDrug DevelopmentCollaborationsChemotherapyGrant
Grant awards (20)
PROGRAM 4 (CLINICAL AND EXPERIMENTAL THERAPEUTICS)$38,634
P30 · FY2012 · CA · contact PI
PROGRAM 4 (CLINICAL AND EXPERIMENTAL THERAPEUTICS)$40,511
P30 · FY2011 · CA · contact PI
PROGRAM 4 (CLINICAL AND EXPERIMENTAL THERAPEUTICS)$44,110
P30 · FY2010 · CA · contact PI
Early Therapeutics Development with Phase II Emphasis$654,110
N01 · FY2009 · CA · contact PI
TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8418 UNDER$650,000
N01 · FY2009 · CA · contact PI
PROGRAM 4 (CLINICAL AND EXPERIMENTAL THERAPEUTICS)$40,312
P30 · FY2009 · CA · contact PI
PROGRAM 4 (CLINICAL AND EXPERIMENTAL THERAPEUTICS)$25,446
P30 · FY2008 · CA · contact PI
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS$1,737,296
N01 · FY2007 · CA · contact PI
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS-261622001$0
N01 · FY2006 · CM · contact PI
CARCINOGENESIS AND NOVEL THERAPEUTICS IN ORAL CANCER$426,346
P50 · FY2001 · DE
CARCINOGENESIS AND NOVEL THERAPEUTICS IN ORAL CANCER$4,553
P50 · FY2001 · DE
CORE--PROTOCOL AND DATA MANAGEMENT OFFICE$0
P30 · FY2001 · CA
CORE--PROTOCOL AND DATA MANAGEMENT OFFICE$0
P30 · FY2001 · CA
PLANNING AND EVALUATION$0
P30 · FY2001 · CA
PLANNING AND EVALUATION$0
P30 · FY2001 · CA
CARCINOGENESIS AND NOVEL THERAPEUTICS IN ORAL CANCER$827,856
P50 · FY2000 · DE
COOPERATIVE STUDY$320,533
U01 · FY2000 · CA
CORE--PROTOCOL AND DATA MANAGEMENT OFFICE$289,716
P30 · FY2000 · CA
PLANNING AND EVALUATION$289,716
P30 · FY2000 · CA
CARCINOGENESIS AND NOVEL THERAPEUTICS IN ORAL CANCER$2,321
P50 · FY2000 · DE